Cancel
See Linkedin
Known information
- Has over 20 years of experience in GxP quality roles at large biopharmaceutical companies.
- Worked at Celgene/BMS, Schering Ag/Bayer, and Regeneron.
- Has expertise in the design, implementation, and oversight of quality management systems and compliance operations.
- Worked with more than 35 different regulatory health authorities across the Americas, Europe, Asia, the Middle East, Russia, Africa, Australia, and Japan.
- Previously served as a Principal Quality Consultant at Halloran Consulting.
- Served as Executive Director, Compliance Operations at Celgene from 2007 to 2020.
- Directed quality improvement initiatives and GMP auditing and training at Schering Ag/Bayer.
- Held a role in Compliance and Quality at Regeneron with responsibility for GLP Quality Assurance.
- Earlier in his career, was a scientist at Baxter.
- Received a B.S. and a B.A. from Rutgers University.
- Earned an M.S. in Jurisprudence from Seton Hall University.
About Acrivon Therapeutics
Acrivon Therapeutics develops precision oncology medicines using a proprietary proteomics-based platform, with its lead candidate ACR-368 in a Phase 2 trial for multiple tumor types.
Report inaccurate information